Skip to main content
Premium Trial:

Request an Annual Quote

NuGenesis, PA Consulting Team Up to Offer Services to Life Science Sector

NEW YORK, March 14 - NuGenesis Technologies, the maker of NuGenesis Scientific Data Management Systems software, said Wednesday it had forged an alliance with PA Consulting Group of London to jointly provide software consulting services to the pharmaceutical and life science sectors.

PA and NuGenesis of Westborough, Mass., said they would work together to help companies implement software tools that would help them throughout the data integration and drug discovery processes.

"Through this alliance we are providing proactive information management solutions for the pharmaceutical and life sciences industries," Michael McGuinness, president of NuGenesis, said in a statement.

"PA enables us to widen our scope through their innovative and pragmatic approach to improve and shorten development time scales,” he said.

Last week IBM announced a similar move, saying it would establish a consulting practice within its Global Services organization to help biotech and pharmaceutical companies use information technology to speed development of medical treatments. A Frost & Sullivan study conducted for IBM predicted that life sciences companies would spend nearly $6.5 billion on IT services by 2004. 

Smaller companies such as Blackstone Technology Group and 3 rd Millennium have built businesses around offering hardware and software consulting services to genomics companies.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more